Data Characteristics for this Category
Bioequivalence product data primarily originates from drug registration submissions. This includes clinical trial reports, pharmacokinetic data, in vitro dissolution profiles, and stability study reports. The data combines structured formats (e.g., clinical data tables, pharmacokinetic parameter tables) and unstructured formats (e.g., study protocols, summary reports, statistical analysis documents). Data update frequency is relatively low, concentrating on submission and approval phases, and post-market supplemental applications. Document types are diverse, including PDF reports, Word documents, Excel spreadsheets, and scanned images. Fields cover pharmacokinetic parameters such as plasma drug concentration, area under the curve (AUC), maximum plasma concentration (Cmax), and time to maximum concentration (Tmax), as well as statistical analysis results (e.g., 90% confidence intervals). Units commonly include ng/mL, h, and μg·h/mL.
Constraints on Vector Models and Indexing from these Characteristics
Accurate retrieval of key pharmacokinetic parameters and statistical results is critical for bioequivalence data. This requires vector models to capture the relationship between numerical values and units, and to differentiate data under various experimental conditions. Large volumes of unstructured text, such as study protocols and reports, necessitate effective text segmentation strategies to prevent information loss or over-generalization. Since some data may exist as scanned images, OCR accuracy directly impacts subsequent text extraction and vectorization quality. Documents contain numerous specialized terms and abbreviations, demanding strong domain knowledge understanding from the model. Furthermore, a low update frequency means the quality of initial index construction significantly influences long-term user experience, requiring meticulous preprocessing and index optimization. For structured data in Excel, specialized parsing logic is necessary to convert it into text segments suitable for vectorization.
Configuration Settings
| Configuration Item | Recommended Value | Rationale for Recommendation |
|---|---|---|
Chunk size (Segment Length) | 800–1200 characters (characters) | Balances contextual completeness and vector retrieval granularity, preventing truncation of critical information. |
Chunk Overlap Length (Segment Overlap Length) | 100 characters (characters) | Ensures contextual continuity between paragraphs, improving hit rates for cross-paragraph queries. |
Recall count (Retrieval Count) | Top 5 entries (top 5) | Prioritizes retrieval of the most relevant segments, considering the precision requirements of bioequivalence queries. |
Similarity threshold (Similarity Threshold) | Calibrate based on actual measurements | Balances recall rate and accuracy based on actual query performance and data characteristics. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | Addresses potentially long parsing times for large PDF reports and complex Excel files. |
MAX_FILE_SIZE_MB | 100 MB | Accommodates report files containing numerous charts and scanned pages. |
Three Common Mistakes
- Knowledge base index creation fails, typically because
PARSE_FILE_TIMEOUT_SECONDSis set too low. This causes parsing to time out for large or complex bioequivalence report files. - Query results have poor relevance. This manifests as returned segments not being highly related to the question. The cause might be an excessively long
Chunk size(segment length), leading to individual vectors containing overly broad information, or an improperly setSimilarity threshold(similarity threshold). - Excel file content is not effectively indexed. This appears as no results for queries on key pharmacokinetic parameters within tables. This happens when the structured nature of Excel files is not specifically handled for parsing and content extraction, and the file is treated as plain text, leading to information loss.
How to Verify Correct Configuration
- After uploading typical bioequivalence reports (PDF, Word, Excel), check if the file status shows "Completed" and confirm that logs show no parsing timeouts or errors.
- Perform precise queries for key pharmacokinetic parameters (e.g., AUC, Cmax values) and statistical results within the reports. Verify that the retrieved segments contain this critical information and its context.
- Test queries containing numerous specialized terms and abbreviations. Confirm the accuracy and relevance of the returned results. A qualified recall rate threshold can be defined based on actual business scenarios.
The values provided are common starting points and should be measured against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.